Factors related to the progression of Chronic Kidney Disease after two years of follow-up of stage 3 Chronic kidney Disease Patients
<p><strong>Background:</strong>The problem of chronic kidney disease (CKD) progression is a panic and it is still inevitable.</p><p><strong>Patients and Methods:</strong> Prospective observational study of factors present at initial evaluation of ...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Book |
Published: |
Archives of Renal Diseases and Management - Peertechz Publications,
2017-08-29.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | peertech__10_17352_2455-5495_000027 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Noemi Esparza Martín |e author |
700 | 1 | 0 | |a Santiago Suria González |e author |
700 | 1 | 0 | |a Elvira Bosch Benítez- Parodi |e author |
700 | 1 | 0 | |a Rita Guerra Rodríguez |e author |
700 | 1 | 0 | |a Germán Pérez Suárez |e author |
700 | 1 | 0 | |a César García Cantón |e author |
245 | 0 | 0 | |a Factors related to the progression of Chronic Kidney Disease after two years of follow-up of stage 3 Chronic kidney Disease Patients |
260 | |b Archives of Renal Diseases and Management - Peertechz Publications, |c 2017-08-29. | ||
520 | |a <p><strong>Background:</strong>The problem of chronic kidney disease (CKD) progression is a panic and it is still inevitable.</p><p><strong>Patients and Methods:</strong> Prospective observational study of factors present at initial evaluation of stage 3 CKD patients proceeding from external consultations after two years of follow-up. Exclusion criteria: Under 40 or older than 79 years old, anemia, previous heart or hepatic failure, valvular or ischemic cardiopathy, arrhythmias, clinical arterial peripheral disease or immunosuppressive treatment. Inclusion criteria: All the incidental patients who wish to participate between January, 2012 and January, 2014. The study was approved by the Committee of Ethics of Clinical Investigation. </p> | ||
540 | |a Copyright © Noemi Esparza Martín et al. | ||
546 | |a en | ||
655 | 7 | |a Abstract |2 local | |
856 | 4 | 1 | |u https://doi.org/10.17352/2455-5495.000027 |z Connect to this object online. |